multiple myeloma Archives

multiple myeloma

FDA approves Farydak for treatment of multiple myeloma

February 27, 2015

On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read more.

FDA approves new treatment for multiple myeloma

December 3, 2015

On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received…

Improving outcomes for patients with multiple myeloma

May 25, 2016

Over the last decade, progress in multiple myeloma (MM) treatment has extended survival with good quality of life. We’ve increased our understanding of how the genetic features of…

New treatment for multiple myeloma

March 8, 2020

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug…